System for targeted delivery of therapeutic agents
5,503,627 A 4/1996 McKinnon etal. 6,399,754 B1 6/2002 C001< _ 5,512,600 A 4/1996
M1kose1a1. 6,403,779 B1 6/2002 Kawasakl et al. 5,514,378 A 5/1996 M1koseta1 …
M1kose1a1. 6,403,779 B1 6/2002 Kawasakl et al. 5,514,378 A 5/1996 M1koseta1 …
Vaccine nanotechnology
2008-11-17 Assigned to THE BRIGHAM AND WOMEN'S HOSPITAL, INC. reassignment
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. ASSIGNMENT OF ASSIGNORS …
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. ASSIGNMENT OF ASSIGNORS …
Vaccine nanotechnology
2013-03-26 Assigned to MASSACHUSETTS INSTITUTE OF TECHNOLOGY reassignment
MASSACHUSETTS INSTITUTE OF TECHNOLOGY ASSIGNMENT OF ASSIGNORS …
MASSACHUSETTS INSTITUTE OF TECHNOLOGY ASSIGNMENT OF ASSIGNORS …
Tolerogenic synthetic nanocarriers for inducing regulatory B cells
RA Maldonado - US Patent 8,652,487, 2014 - Google Patents
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C ([C@ H](NC (=
O)[C@ H](C (C) C) NC (= O) CNC (= O)[C@ H](CCC (O)= O) NC (= O)[C@ H](CCCNC (N) …
O)[C@ H](C (C) C) NC (= O) CNC (= O)[C@ H](CCC (O)= O) NC (= O)[C@ H](CCCNC (N) …
Targeting of antigen presenting cells with immunonanotherapeutics
2010-07-19 Assigned to THE BRIGHAM AND WOMEN'S HOSPITAL, INC. reassignment
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. ASSIGNMENT OF ASSIGNORS …
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. ASSIGNMENT OF ASSIGNORS …
System for targeted delivery of therapeutic agents
The present invention provides a drug delivery system for targeted delivery of therapeutic
agent-containing particles to tissues, cells, and intracellular compartments. The invention …
agent-containing particles to tissues, cells, and intracellular compartments. The invention …
Adjuvant incorporation in immunonanotherapeutics
2010-01-12 Assigned to PRESIDENT AND FELLOWS OF HARVARD COLLEGE
reassignment PRESIDENT AND FELLOWS OF HARVARD COLLEGE ASSIGNMENT OF …
reassignment PRESIDENT AND FELLOWS OF HARVARD COLLEGE ASSIGNMENT OF …
Microfluidic synthesis of organic nanoparticles
5,174.930 A 12/1992 Stainmesse 6,095,148 A 8, 2000 Shastri et al. 5,175,296 A 12/1992
Gerster 6,107,094. A 8/2000 Crooke 5, 190,521. A 3/1993 Hubbard et al. 6,110,462 A …
Gerster 6,107,094. A 8/2000 Crooke 5, 190,521. A 3/1993 Hubbard et al. 6,110,462 A …
Nanoparticles for immunotherapy
Nanoparticles that activate complement in the absence of biological molecules are
described. The nanoparticles are shown to speci? cally target antigen presenting cells in …
described. The nanoparticles are shown to speci? cally target antigen presenting cells in …
Adjuvant incorporation in immunoanotherapeutics
2013-12-31 Assigned to PRESIDENT AND FELLOWS OF HARVARD COLLEGE
reassignment PRESIDENT AND FELLOWS OF HARVARD COLLEGE ASSIGNMENT OF …
reassignment PRESIDENT AND FELLOWS OF HARVARD COLLEGE ASSIGNMENT OF …